loadpatents
name:-0.012560844421387
name:-0.011996984481812
name:-0.0024209022521973
Cardinal; John R. Patent Filings

Cardinal; John R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cardinal; John R..The latest application filed is for "novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative".

Company Profile
0.9.10
  • Cardinal; John R. - Tamarac FL
  • Cardinal; John R. - Wilmington NC
  • Cardinal; John R. - Old Lyme CT
  • Cardinal; John R. - Groton CT
  • Cardinal; John R. - North Wales PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Novel Pharmaceutical Formulation Containing A Biguanide And A Thiazolidinedione Derivative
App 20150072001 - Kositprapa; Unchalee ;   et al.
2015-03-12
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
Grant 8,668,931 - Kositprapa , et al. March 11, 2
2014-03-11
Novel Pharmaceutical Formulation Containing A Biguanide And A Thiazolidinedione Derivative
App 20130266647 - Kositprapa; Unchalee ;   et al.
2013-10-10
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
Grant 8,470,368 - Kositprapa , et al. June 25, 2
2013-06-25
Methods And Formulations For Treating Sialic Acid Deficiencies
App 20130109637 - Kakkis; Emil ;   et al.
2013-05-02
Novel Pharmaceutical Formulation Containing A Biguanide And A Thiazolidinedione Derivative
App 20110262538 - Kositprapa; Unchalee ;   et al.
2011-10-27
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
Grant 7,959,946 - Kositprapa , et al. June 14, 2
2011-06-14
Extended-release Pharmaceutical Formulations
App 20100160363 - Cardinal; John R. ;   et al.
2010-06-24
Extended-Release Pharmaceutical Formulations
App 20100159001 - Cardinal; John R. ;   et al.
2010-06-24
Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
App 20050051922 - Nangia, Avinash ;   et al.
2005-03-10
Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
App 20050048119 - Nangia, Avinash ;   et al.
2005-03-03
Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid
App 20040166162 - Niecestro, Robert ;   et al.
2004-08-26
Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
App 20040161462 - Kositprapa, Unchalee ;   et al.
2004-08-19
Asymmetric membranes in delivery devices
Grant 5,698,220 - Cardinal , et al. December 16, 1
1997-12-16
Use of asymmetric membranes in delivery devices
Grant 5,612,059 - Cardinal , et al. March 18, 1
1997-03-18
Orifice insert for a ruminal bolus
Grant 5,122,128 - Cardinal , et al. June 16, 1
1992-06-16
Chitosan compositions for controlled and prolonged release of macromolecules
Grant 4,895,724 - Cardinal , et al. January 23, 1
1990-01-23
Laminate device for controlled and prolonged release of substances to an ambient environment and method of use
Grant 4,601,893 - Cardinal July 22, 1
1986-07-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed